NEW YORK LIFE INVESTMENT MANAGEMENT LLCNEW YORK LIFE INVESTMENT MANAGEMENT LLC

Institutional investor · Portfolio as of Q3 2020

SEC EDGAR SourceSEC Filings

Top Holdings26 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
CLRGCLRGDelisted
ETF

IQ U.S. Large Cap ETF

9.6M$242.2M22.0%$21.49+11.12%
7 qtrssince 2019-Q1
Increased
61
IQINIQINDelisted
ETF

NYLI 500 International ETF

9.1M$224.1M20.3%$19.36+9.59%
7 qtrssince 2019-Q1
Decreased
0
IQSUIQSU
ETF

NEW YORK LIFE INVESTMENTS ET

5.1M$148.3M13.4%$25.88+4.18%
2 qtrssince 2020-Q2
Increased
96
HFXIHFXI
ETF

NYLI FTSE INTERNATIONAL EQUITY CURRENCY NEUTRAL ETF

6.9M$137.7M12.5%$15.66+6.22%
7 qtrssince 2019-Q1
Decreased
0
IQSIIQSI
ETF

NEW YORK LIFE INVESTMENTS ET

4.2M$99.7M9.0%$19.70+5.11%
2 qtrssince 2020-Q2
Increased
65
CSMLCSMLDelisted
ETF

IQ U.S. Small Cap ETF

3.9M$86.8M7.9%$23.02-8.58%
7 qtrssince 2019-Q1
Increased
65
HYLVHYLVDelisted
ETF

IndexIQ ETF Trust IQ S&P High Y

2.2M$54.8M5.0%$24.11+2.53%
2 qtrssince 2020-Q2
Increased
56
SHVSHV
ETF

ISHARES SHORT TREASURY BOND

157,474$17.4M1.6%$90.67+2.53%
7 qtrssince 2019-Q1
Unchanged
0
MGCMGC
ETF

VANGUARD MEGA CAP ETF

111,989$13.4M1.2%$108.51+2.17%
2 qtrssince 2020-Q2
Increased
72
VOEVOE
ETF

VANGUARD MID-CAP VALUE ETF

131,009$13.3M1.2%$79.31+13.13%
7 qtrssince 2019-Q1
Decreased
0
IWDIWD
ETF

ISHARES TR RUSSELL 1000 VALUE INDEX FUND

84,961$10M0.9%$102.41+3.48%
4 qtrssince 2019-Q4
Decreased
0
AGGAGG
ETF

ISHARES TR

68,530$8.1M0.7%$98.75+0.07%
2 qtrssince 2020-Q2
Increased
63
SCHZSCHZ
ETF

SCHWAB US AGGREGATE BOND ETF

144,170$8.1M0.7%$23.66+0.14%
2 qtrssince 2020-Q2
Increased
63
IEFAIEFA
ETF

ISHARES CORE MSCI EAFE ETF

118,235$7.1M0.6%$50.56+0.93%
2 qtrssince 2020-Q2
Increased
63
BILBIL
ETF

SPDR BLOOMBERG 1-3 MONTH T-B

64,581$5.9M0.5%$76.77+1.90%
7 qtrssince 2019-Q1
Unchanged
0
BKLNBKLN
ETF

INVESCO EXCH TRADED FD TR II

218,545$4.8M0.4%$14.77+2.23%
7 qtrssince 2019-Q1
Increased
37
VCITVCIT
ETF

VANGUARD INT-TERM CORPORATE

55,770$4.7M0.4%$67.77+15.74%
7 qtrssince 2019-Q1
Unchanged
0
GBILGBIL
ETF

GOLDMAN SACHS ETF TR

27,550$2.8M0.3%$83.77+2.53%
7 qtrssince 2019-Q1
Unchanged
0
SCZSCZ
ETF

ISHARES TR

47,018$2.7M0.2%$46.99+7.47%
7 qtrssince 2019-Q1
Unchanged
0
VOVO
ETF

VANGUARD MID-CAP ETF

14,681$2.6M0.2%$39.80+1.50%
2 qtrssince 2020-Q2
Increased
52
$1.1B
AUM
26
Positions
Q3 2020
Filing
Rating · 4.0
Quarterly Portfolio Change
-16%Q2'19$1.1B-21%Q3'19$860.7M-21%Q4'19$681M-7%Q1'20$633.5M+49%Q2'20$946.4M+17%Q3'20$1.1B
Activity profile
$ moved · Q3'20
New0%Increased84%Decreased16%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.9 quarters
<1Q0%1-4Q42%1-2Y58%2Y+0%

NEW YORK LIFE INVESTMENT MANAGEMENT LLC manages $1.1B across 26 positions as of Q3 2020. Top holdings: CLRG (22.0%), IQIN (20.3%), IQSU (13.4%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 4/5.0.

Q3 2020 Summary

Increased 15, trimmed 5. Top move: IQSU (INCREASED, conviction 96). Portfolio: $1.1B across 26 positions.

Top holdings by portfolio weight

Total AUM$1B
CLRG21.96%
IQIN20.32%
IQSU13.44%
HFXI12.48%
IQSI9.04%
CSML7.87%
HYLV4.96%
SHV1.58%
MGC1.22%
VOE1.20%
Other0.91%

Portfolio allocation by GICS sector

Sectors1
Unknown100.00%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown
Compare DNA across all funds
7-dimension quality assessment
Strong(4.0 / 5.0)
Track Record71
Conviction40
Concentration43
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
USHYUSHYISHARES BROAD USD HIGH YIELD
Q3 2024 Q2 2026+906,416 shares+$33.7M
7Q
APHAPHAMPHENOL CORP-CL A
Q4 2024 Q2 2026+10,995 shares+$19.8M
7Q
ATOATOATMOS ENERGY CORP
Q4 2024 Q2 2026+2,574 shares+$1.1M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used